From: A multicenter cross-sectional French study of the impact of COVID-19 on neuromuscular diseases
Myasthenia | n | Myopathy | n | Neuropathy | n |
---|---|---|---|---|---|
Autoimmune myasthenia gravis | 32 | Becker muscular dystrophy | 1 | Anti-MAG neuropathy | 1 |
Congenital myasthenic syndromes | 2 | Beta sarcoglycanopathy | 1 | Chronic Ataxic Neuropathy, Ophtamoplegia, IgM paraprotein, cold Agglutinins and Disialosyl antibodies | 1 |
Calpainopathy (LGMD2A) | 3 | Cerebellar Ataxia, Neuropathy, Vestibular Areflexia Syndrome | 1 | ||
Congenital muscular dystrophy | 1 | Charcot-Marie-Tooth disease | 8 | ||
Congenital myotonia (Becker) | 1 | Chronic demyelinating inflammatory polyradiculoneuritis | 4 | ||
Duchenne muscular dystrophy | 3 | Hereditary amyloid neuropathy | 2 | ||
Gamma sarcoglycanopathy | 1 | Mitochondrial cytopathy | 1 | ||
GNE myopathy | 2 | Multifocal motor neuropathy | 2 | ||
Inclusion body myositis | 1 | Neuromyotonia | 1 | ||
Limb-girdle muscular dystrophy | 1 | Sensory neuropathy | 2 | ||
Mitochondrial myopathy | 1 | ||||
Muscle channelopathy | 1 | ||||
Myofibrillary myopathy | 1 | ||||
Myositis | 1 | ||||
Type 1 myotonic dystrophy (Steinert) | 4 | ||||
Type 2 myotonic dystrophy (PROMM) | 1 | ||||
Type 3 glycogenosis | 2 | ||||
Unlabeled myopathy | 1 | ||||
34 | 27 | 23 |